Compare ESTC & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESTC | STVN |
|---|---|---|
| Founded | 2012 | 1949 |
| Country | Netherlands | Italy |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Containers/Packaging |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 7.4B |
| IPO Year | 2018 | 2021 |
| Metric | ESTC | STVN |
|---|---|---|
| Price | $78.23 | $22.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 4 |
| Target Price | ★ $107.38 | $25.38 |
| AVG Volume (30 Days) | ★ 2.4M | 339.1K |
| Earning Date | 11-20-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | N/A | ★ 19.61 |
| EPS | N/A | ★ 0.60 |
| Revenue | ★ $1,609,284,000.00 | $1,373,219,524.00 |
| Revenue This Year | $18.25 | $8.42 |
| Revenue Next Year | $13.63 | $9.52 |
| P/E Ratio | ★ N/A | $36.82 |
| Revenue Growth | ★ 16.98 | 6.97 |
| 52 Week Low | $68.10 | $17.81 |
| 52 Week High | $118.84 | $28.00 |
| Indicator | ESTC | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 39.72 |
| Support Level | $73.92 | $20.62 |
| Resistance Level | $79.87 | $23.88 |
| Average True Range (ATR) | 2.13 | 1.11 |
| MACD | 0.86 | -0.07 |
| Stochastic Oscillator | 86.53 | 11.50 |
Elastic is a software company that specializes in AI-search, observability, and security deployments. Its search division offers both traditional keyword search and vector search methods to enable more context-aware querying. The software has open-source origins but generates revenue through valuable add-ons, including simplified data orchestration and server scaling techniques.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.